THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTA

COVID 19 服务促进公共卫生变革的转化研究成果，通过实施应对新型冠状病毒大流行

• 批准号: 10500611
• 负责人: LEONARD FREEDMAN
• 金额: $ 61.29万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-31 至 2021-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10500611
• 关键词: ACE2; Address; Biological; Biological Sciences; COVID-19; COVID-19 assay; Client; Contracts; Crystallography; Laboratories; Ligands; Peptides; Production; Public Health; Research Activity; Research Personnel; Services; Translational Research; diagnostic assay; experience; novel coronavirus; pandemic disease; programs; research and development; scale up

Advanced BioScience Laboratories, Inc. (ABL) is a global contract manufacturing organization with experience in biologics R&D, scale-up, and production following current Good Manufacturing Practices (cGMP). ABL partners with our clients to support GMP manufacturing needs. Dr. Wlodawer, Chief of the Macromolecular Crystallography Laboratory with the NCI-Frederick is working on a project, Chimeric ACE2 Peptide Ligand for Diagnostic Assays of SARS-CoV-2, under the Intramural Targeted Anti-Covid19 (ITAC) Program, which provides supplementary support for COVID-19 research activities for intramural investigators

Advanced BioScience Laboratories，Inc. (ABL)是一家全球性的合同生产组织，在生物制剂研发、扩大规模和生产方面拥有丰富的经验，符合现行的良好生产规范（cGMP）。ABL与我们的客户合作，以支持GMP生产需求。 Wlodawer博士是NCI-Frederick大分子晶体学实验室的负责人，他正在研究一个项目，在校内靶向抗Covid 19（ITAC）计划下，用于SARS-CoV-2诊断分析的嵌合ACE 2肽配体，该项目为校内研究人员的COVID-19研究活动提供补充支持